The Endocannabinoid System of Animals

por Silver, Robert J.
Publicado 2019

Abstract 5: Similar hypoglycemia duration with once-weekly insulin icodec versus insulin glargine U100 in insulin naïve or experienced patients with T2D

por Manjunath, Aparna, Silver, Robert J, Asong, Marisse, Begtrup, Kamilla, Koefoed, Mette M, Heller, Simon R, Rosenstock, Julio
Publicado 2022

Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled T...

por Bajaj, Harpreet S., Bergenstal, Richard M., Christoffersen, Andreas, Davies, Melanie J., Gowda, Amoolya, Isendahl, Joakim, Lingvay, Ildiko, Senior, Peter A., Silver, Robert J., Trevisan, Roberto, Rosenstock, Julio
Publicado 2021

Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial

por Bain, Stephen C., Mosenzon, Ofri, Arechavaleta, Rosario, Bogdański, Pawel, Comlekci, Abdurrahman, Consoli, Agostino, Deerochanawong, Chaicharn, Dungan, Kathleen, Faingold, Maria C., Farkouh, Michael E., Franco, Denise R., Gram, Jeppe, Guja, Cristian, Joshi, Pankaj, Malek, Rachid, Merino‐Torres, Juan F., Nauck, Michael A., Pedersen, Sue D., Sheu, Wayne H. ‐H., Silver, Robert J., Tack, Cees J., Tandon, Nikhil, Jeppesen, Ole K., Strange, Mette, Thomsen, Mette, Husain, Mansoor
Publicado 2018